Nature7h
US drug agency approves potent painkiller — the first non-opioid in decades
The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.
US FDA identifies cybersecurity risks in certain patient monitors
The U.S. Food and Drug Administration (FDA) said on Thursday it had identified three cybersecurity risks associated with ...
GEN11h
As Pipeline Advances, Recursion Expands AI Focus to Clinical Trials
Chief R&D and commercial officer Najat Khan, PhD, tells GEN Edge company aims to improve design of studies, accelerate enrollment, and enhance evidence generation.
JD Supra13h
International AI Regulatory Contrast: Evolving frameworks in the EU, UK, and US
In the EU, the AI Act has been approved, carrying significant implications for medical device, technology, and pharmaceutical firms. In the US, ...
Merck to stop lung condition drug study early due to strong efficacy data
Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...
The Economist20h
Many governments talk about cutting regulation but few manage to
H e brandished a chainsaw at campaign rallies, to signify his eagerness to clear-cut the thickets of bureaucracy and ...
Dollar Falls Ahead of U.S. Economic Growth Data
The dollar was falling on caution ahead of key U.S. economic growth data for the fourth quarter of 2024, as it risks falling in the event of a weak reading. "I have always argued that the U.S. growth ...